MMedXYNews
Ask AIHomeVideos
© 2026 MedXY
Contact usAbout usPrivacy PolicyMedXY story
MedXY News/Psychiatry

Section

Psychiatry

423 articles

Ask AI
All specialtiesPsychiatrynewsClinical UpdatesCardiologyOncology

Latest updates

news

Leucovorin for Autism Spectrum Disorder: Navigating Clinical Efficacy and Regulatory Controversy

This article evaluates the clinical evidence supporting leucovorin for autism spectrum disorder and examines the FDA’s controversial proposal to expand its indications based on mechanistic data rather than traditional large-scale clin

Jan 25, 2026
Diabetes & Endocrinology

Smart Speakers for Diabetes: Bridging the Gap Between Mental Wellbeing and Glycemic Control in Older Adults

The IVAM-ED trial demonstrates that interactive virtual assistants significantly reduce mental distress and improve HbA1c levels in older adults with type 2 diabetes, highlighting a scalable solution for geriatric chronic disease management

Jan 24, 2026Sign in to read
Cardiology

Keto vs. Mediterranean: New Evidence on Which Diet Wins for Heart and Brain Health

This article compares the Ketogenic and Mediterranean diets’ impact on cardiovascular markers and mental health, highlighting results from two recent pilot studies on blood pressure and the gut-brain axis.

Jan 20, 2026
news

ACT-Based Parenting Interventions Significantly Reduce Caregiver Stress and Improve Child Outcomes in Autism Spectrum Disorder

A randomized clinical trial demonstrates that an 8-week Acceptance and Commitment Therapy (ACT) program significantly reduces parental stress and improves psychological flexibility and parenting competence, while also yielding positive seco

Jan 16, 2026Sign in to read
news

Balancing the Scale: Early Antipsychotic Dose Reduction Linked to Better Long-term Functioning Despite Short-term Relapse Risks

The HAMLETT trial demonstrates that early dose reduction after first-episode psychosis increases short-term relapse risk but correlates with superior functional outcomes at three to four years, suggesting a potential ‘learning effect&

Jan 16, 2026
news

Scalable Success: Electronic Patient-Managed Interventions Significantly Drive Benzodiazepine Cessation

The EMPOWER-ED randomized clinical trial demonstrates that an electronic, patient-centered intervention significantly increases the odds of complete benzodiazepine cessation among long-term users, providing a scalable, low-cost solution for

Jan 16, 2026
Neurology

Reevaluating the Efficacy of Music Interventions in Dementia-Related Depression: Critical Insights from the MIDDEL Multinational Trial

Highlights Background Dementia and depression are intertwined public health crises, together accounting for a substantial...

Jan 13, 2026Sign in to read
MMedXY
News
Hematology-Oncology

Music Therapy Proves Noninferior to Cognitive Behavioral Therapy for Managing Anxiety in Cancer Survivors: Results from a Randomized Trial

A randomized clinical trial demonstrates that telehealth-delivered music therapy is noninferior to cognitive behavioral therapy for reducing anxiety in cancer survivors, providing durable, clinically meaningful improvements and a viable alt

Jan 8, 2026
Neurology

Post-TIA Depression: A Silent Predictor of Mortality and Long-Term Disability Independent of Brain Ischemia

A population-based study reveals that nearly one-quarter of TIA patients experience depression, which significantly increases the risk of mortality and disability, regardless of whether acute ischemic lesions are present on imaging.

Jan 7, 2026
Cardiology

The Hidden Burden of Heart and Brain Health: ASCVD Linked to Significantly Elevated Suicide Risk

A large-scale nationwide study reveals that individuals with atherosclerotic cardiovascular disease (ASCVD), including myocardial infarction and stroke, face a 43% higher risk of suicide. The risk nearly doubles for those suffering from bot

Jan 7, 2026
news

Beyond Picky Eating: Large-Scale Study Reveals the Genetic Architecture and Developmental Impact of ARFI Phenotypes

This large-scale study of 35,751 children characterizes ARFI phenotypes, revealing a 6.3% clinical prevalence and significant genetic heritability. Findings link ARFI to the ADCY3 locus and long-term neurodevelopmental difficulties, emphasi

Jan 6, 2026
Clinical Updates

Neuropsychiatric Interaction with Vascular Health: Deciphering the Moderating Role of PTSD in Hormonal Contraceptive-Associated Cardiovascular Risk

A large-scale cohort study demonstrates that while hormonal contraceptives are generally associated with lower cardiovascular risk in women, this protective effect is lost in those with PTSD, highlighting a critical intersection between psy

Jan 6, 2026
news

Adjunctive Omega-3 Supplementation Does Not Improve Pediatric Major Depressive Disorder: Insights from a Multi-Center Randomized Trial

A multi-center randomized clinical trial involving 257 youths found that adjunctive omega-3 fatty acids (1.5 g/d) did not outperform placebo in treating moderate-to-severe pediatric major depressive disorder, despite high adherence and conc

Jan 6, 2026
Neurology

Digital Phenotyping in Insomnia: Real-Time Smartphone Assessment Detects Daytime Benefits of Suvorexant Missed by Traditional Scales

A randomized clinical trial demonstrates that smartphone-based ecological momentary assessment (EMA) is significantly more sensitive than retrospective questionnaires in detecting the daytime clinical benefits of suvorexant, particularly re

Jan 6, 2026
Cardiology

Mental Health Labels Linked to Critical Delays and Doubled Five-Year Mortality in STEMI Care

A prospective study reveals that patients with mental health conditions face significant delays in STEMI diagnosis, resulting in larger infarct sizes and a twofold increase in five-year cardiovascular mortality compared to those without suc

Jan 3, 2026
Neurology

A Global Standard: Understanding the New VasCog-2-WSO Criteria for Vascular Dementia

Experts have released the VasCog-2-WSO criteria, an updated international standard for diagnosing vascular cognitive impairment and dementia. This revision introduces a preclinical stage and incorporates modern neuroimaging and fluid biomar

Jan 2, 2026
Internal Medicine

The Limits of Collaborative Care: Why the CLARO Trial Found No Added Benefit for OUD and Comorbid Mental Illness

The CLARO randomized clinical trial investigated whether a collaborative care model could improve outcomes for patients with opioid use disorder and co-occurring depression or PTSD. The study found no statistically significant advantages ov

Jan 1, 2026Sign in to read
Internal Medicine

Low-Dose Amitriptyline vs. CBT-I for Comorbid Insomnia: Statistical Non-Inferiority Meets Clinical Reality

A multicenter trial finds low-dose amitriptyline non-inferior to CBT-I for comorbid insomnia based on a liberal margin. However, CBT-I yielded superior clinical response rates and fewer side effects, reinforcing its status as the gold-stand

Dec 30, 2025Sign in to read
Neurology

Tai Chi as a Long-term Alternative to CBT-I for Chronic Insomnia in Older Adults: A Randomized Non-inferiority Trial

A randomized trial comparing Tai Chi and CBT-I in adults over 50 found that while CBT-I offers faster relief, Tai Chi achieves non-inferior results at 12 months post-intervention, suggesting it is a viable long-term strategy for insomnia ma

Dec 30, 2025
news

Lifespan Management of ADHD: Landmark Umbrella Review Identifies Optimal Interventions and Critical Evidence Gaps

A comprehensive BMJ umbrella review synthesizes evidence for ADHD interventions across the lifespan, confirming the efficacy of stimulants and non-stimulants in the short term while revealing a critical lack of high-certainty long-term data

Dec 30, 2025
Previous
11 / 22
1…910111213…22
Next

Go deeper with MedXY AI

Explore the evidence behind the news.

Ask AI
MedXY briefing

Stay informed

Medical news and research updates, delivered to your inbox.